Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer
- 30 April 2009
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 94 (2), 638-644
- https://doi.org/10.1016/j.fertnstert.2009.03.045
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormoneFertility and Sterility, 2008
- Fertility and Menopausal Outcomes in Young Breast Cancer SurvivorsClinical Breast Cancer, 2008
- Amenorrhea in Premenopausal Women After Adjuvant Chemotherapy for Breast CancerJournal of Clinical Oncology, 2006
- Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilizationFertility and Sterility, 2003
- Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserveFertility and Sterility, 2002
- Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormoneFertility and Sterility, 1999
- Ovarian reserve tests in infertility practice and normal fertile womenMaturitas, 1998
- Treatment-independent pregnancy rate in patients with severe reproductive disordersHuman Reproduction, 1998
- Use of the Antral Follicle Count to Predict the Outcome of Assisted Reproductive TechnologiesFertility and Sterility, 1998
- Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than ageFertility and Sterility, 1991